Ms. Brigitte Simons reports

SAFARI FLOWER COMPANY, A WHOLLY OWNED SUBSIDIARY OF AURORA CANNABIS, RECEIVES EU-GMP CERTIFICATION AT NIAGARA FACILITY

Safari Flower Company, a wholly owned subsidiary of Aurora Cannabis Inc., has received European Union good manufacturing practice (EU-GMP) certification for its Ontario facility, solidifying its ability to serve international medical cannabis markets. The certification is granted for a three-year term and validates Safari Flower's unwavering commitment to meeting the highest international standards for quality, compliance and operational excellence.

"We are incredibly proud to achieve the highest level of EU-GMP certification, which reinforces our position as a trusted cultivator and manufacturer of high-quality medical cannabis for international markets," said Brigitte Simons, chief executive officer of Safari Flower Company. "This milestone reflects the strong culture of compliance, quality and operational excellence embedded across our facility and the trusted partnerships required to serve regulated supply chains. It further positions Safari to support the evolving needs of medical cannabis markets globally."

Safari's facility is a 59,000-square-foot cultivation and manufacturing site in the Niagara region of Ontario, Canada, with a history of EU-GMP accreditations and exporting operations. Aurora acquired Safari Flower in April, 2026, to provide incremental EU-GMP capacity to align with the company's existing global manufacturing network and to support supply of high-quality medical cannabis to international markets including Germany, Poland and the United Kingdom.

As international medical cannabis markets continue to evolve, EU-GMP certification remains a critical enabler of Safari's ability to serve regulated markets with confidence. The company is proud to be a trusted supplier of high-quality medical cannabis to markets that require rigorous quality, safety and compliance standards and to meet rapidly evolving patient demand.

About Safari Flower Company

Safari Flower is a wholly owned subsidiary of Aurora Cannabis, producing cannabis in the Niagara region of Ontario, Canada. As a licensed operator, it is committed to producing safe medical products and enabling services to scale Canadian exports to international markets.

About Aurora Cannabis Inc.

Aurora is a global leader in medical cannabis, dedicated to improving lives through scientific expertise, proven performance and a deep commitment to patient care. Aurora serves medical markets across Canada, Europe, Australia and New Zealand with a portfolio of trusted, leading brands including Aurora, MedReleaf, Pedanios, IndiMed, San Raf and Whistler Medical Marijuana Corp. With world-class GMP-certified (good manufacturing practice) manufacturing facilities in Canada and Germany and a team of industry-leading professionals, Aurora continues to expand its global footprint and deliver consistent, high-quality cannabis products with the purpose of opening the world to cannabis.

Aurora's common shares trade on the Nasdaq Stock Market and the Toronto Stock Exchange under the symbol ACB.

We seek Safe Harbor.